CLINICAL EXPERIENCE OF PROLONGED AVASTIN THERAPY IN METASTATIC COLORECTAL CANCER

Cover Page

Cite item

Full Text

Abstract

Avastin in combination with standard chemotherapy (CT) is an effective treatment regimen in 1st and 2nd line metastatic colorectal cancer (mCRC). Data of observational cohort programs and results of a randomized TML trial confirmed the efficacy of Avastin plus CT continued beyond first progression in patients with mCRC previously treated with Avastin plus CT.

Author presents her own experience of prolonged Avastin therapy combined with several serial CT lines in mCRC patient

About the authors

A. F. Saidullaeva

Tver Regional Oncology Dispansery

Author for correspondence.
Email: sashatv07@mail.ru
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 85909 от  25.08.2023.